Abstract:Objective To evaluate the effectiveness of terazosin, tamsulosin and fin asteride for benign prostatic hyperplasia (BPH). Methods We searched the related original studies all over the world , and only included randomized controlled trials (RCT) and quasi-randomized con trolled trials (CCT). MEDLINE (1966Dec. 2004), EMBASE (1984Dec . 2004), The Cochrane Library (Issue 4, 2004) and four Chinese databases were electronically searched and 10 related journals were handsearched . The studies included in the references of eligible studies were additionally searched. Two reviewers independently screened the studies for eligibility, eva luated the quality and extracted the data from the eligible studies, with confir mation by cross-checking. Divergences of opinion were consulted by a third part y. Meta-analysis was performed by using RevMan 4.2 software. Results Twelve original studies involving 2 471 participants met inclusion criteria. Compared with terazosin, tamsulosin could improve inter national prostatic symptom score, with WMD 0.75, 95% confidence interval (CI) 0.03 to 1 .46, P=0.04. There was no statistical difference between teraz osin and tamsulosin in improving the average rate of urine flow (WMD 0.23, 95%C I -0.39 to 0.85, P= 0.46), the residual urine volume (WMD 0.82, 95%CI -2.92 to 4.57, P =0.67) and in diminishing the volume of prostate (WMD=2.20, 95%CI -3 .99 to 8.39, P=0.49). There was no statistical difference bet ween finasteride and tamsulosin in improving the international prostatic symptom score (WMD 0.65, 95%CI -0.45 to 1.75, P=0.25) or the max r ate of urine flow (WMD 0.39, 95%CI -0.72 to 1.51, P=0.49). Only two studies compared finasteride with terazosin and had different conclusio ns. Only one study compared finasteride or terazosin with a combination of these drugs suggested that the combination had higher effective power than finasterid e alone but no difference with terazosin alone. Conclusions Although the effectiveness in some aspects is higher in the tamsul osin group, there is not enough evidence to show which one is the best among the se three drugs. The combination of finasteride and terazosin does not show more effectiveness than terazosin alone. This review suggests that tamsulosin alone s hould be used for the treatment of BPH and the combination needs to be identifie d by better evidence. It is important to improve the quality of original studies .

Evaluation on Safety and Efficacy of Finasteride in Treatment of Benign Prostatic Hyperplasia

Evaluation of the Effectiveness of Terazosin, Tamsulosin a nd Finasteride for Benign Prostatic Hyperplasia

Clinical effects of long-term use of finasteride in treatment of patients with benign prostatic hyperplasia

Comparison of Different Drugs on the Treatment of Benign Prostate Hyperplasia

Observation on Curative Efficacy of Tamsulosin Hydrochloride Sustained-Release Capsules Combined with Finasteride Tablets in the Treatment of Benign Prostatic Hyperplasia

A Systematic Review and Meta-Analysis of the Efficacy and Safety of Tamsulosin Plus Tadalafil Compared With Tamsulosin Alone in Treating Males With Lower Urinary Tract Symptoms Secondary to Benign Prostrate Hyperplasia

Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.

The Safety of Dutasteride in the Treatment of Benign Prostatic Hyperplasia:A Meta-analysis

Pharmacoeconomic Evaluation of Tamsulosin Hydrochloride Sustained-release Capsules in the Treatment of Benign Prostatic Hyperplasia

[Cost and Effectiveness Analysis of Treatments for Benign Prostatic Hyperplasia].

The comparison between finasteride and tamsulosin therapeutic efficacy in the treatment of symptomatic benign prostate hyperplasia

Dutasteride for the Treatment of Benign Prostatic Hyperplasia:a Review of Efficacy, Safety and Cost-effectiveness

Clinical observation of Qianlie Shutong Capsules combined with finasteride in treatment of benign prostatic hyperplasia

Tamsulosin Versus Terazosin for Benign Prostatic Hyperplasia: A Systematic Review

The Efficacy of 3-Year Therapy of Finasteride in Patients with Benign Prostatic Hyperplasia

The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews.

Clinical Analysis on the High-Risk BPH Treated by Partial Transurethral Remove of Prostate and Oral Finasteride (69 Cases)

Tamsulosin versus terazosin for benign prostatic hyperplasia: a systematic review.

The Efficacy and Safety of Alpha-1 Blockers for Benign Prostatic Hyperplasia: an Overview of 15 Systematic Reviews

To evaluate the efficacy and safety of different kinds of PDE5-Is with tamsulosin as a medical therapy for LUTS secondary to benign prostatic hyperplasia

Systematic review and meta-analysis of efficacy and safety of silodosin in treatment of benign prostatic hyperplasia patients with lower urinary tract symptoms